[1]
|
Simmons, D.J. (1963) Cellular Changes in the Bones of Mice as Studied with Tritiated Thymidine and the Effects of Estrogen. Clinical Orthopaedics and Related Research, 26, 176-189.
|
[2]
|
Young, M.H. and Crane, W.A. (1964) Effect of Hydrocortisone on the Utilization of Tritiated Thymidine for Skeletal Growth in the Rat. Annals of the Rheumatic Diseases, 23, 163-168.
http://dx.doi.org/10.1136/ard.23.2.163
|
[3]
|
Russell, R.G., Kisling, A.M., Casey, P.A., Fleisch, H., Thornton, J., Schenk, R. and Williams, D.A. (1973) Effect of Diphosphonates and Calcitonin on the Chemistry and Quantitative Histology of Rat Bone. Calcified Tissue Research, 11, 179-195. http://dx.doi.org/10.1007/BF02547218
|
[4]
|
Stutzer, A., Fleisch, H. and Trechsel, U. (1988) Short- and Long-Term Effects of a Single Dose of Bisphosphonates on Retinoid-Induced Bone Resorption in Thyroparathyroidectomized Rats. Calcified Tissue International, 43, 294-299.
http://dx.doi.org/10.1007/BF02556639
|
[5]
|
Wronski, T.J., Dann, L.M., Scott, K.S. and Crooke, L.R. (1989) Endocrine and Pharmacological Suppressors of Bone Turnover Protect against Osteopenia in Ovariectomized Rats. Endocrinology, 125, 810-816.
http://dx.doi.org/10.1210/endo-125-2-810
|
[6]
|
Lin, B.Y., Jee, W.S., Ma, Y.F., Ke, H.Z., Kimmel, D.B. and Li, X.J. (1994) Effects of Prostaglandin E2 and Risedronate Administration on Cancellous Bone in Older Female Rats. Bone, 15, 489-496.
http://dx.doi.org/10.1016/8756-3282(94)90272-0
|
[7]
|
Turan, B., Balcik, C. and Akkas, N. (1997) Effect of Dietary Selenium and Vitamin E on Biochemical Properties of Rabbit Bone. Clinical Rheumatology, 16, 441-449. http://dx.doi.org/10.1007/BF02238935
|
[8]
|
Fleisch, H. (1998) Bisphosphonates: Mechanisms of Action. Endocrine Reviews, 19, 80-100.
http://dx.doi.org/10.1210/edrv.19.1.0325
|
[9]
|
Fleisch, H., Russell, R.G. and Francis, M.D. (1969) Diphosphonates Inhibit Hydroxyapatite Dissolution in Vitro and Bone Resorption in Tissue Culture and in Vivo. Science, 165, 1262-1264.
http://dx.doi.org/10.1126/science.165.3899.1262
|
[10]
|
Francis, M.D., Graham, R., Russell, R.G. and Fleisch, H. (1969) Diphosphonates Inhibit Formation of Calcium Phosphate Crystals in Vitro and Pathological Calcification in Vivo. Science, 165, 1264-1266.
http://dx.doi.org/10.1126/science.165.3899.1264
|
[11]
|
Green, J.R., Muller, K. and Jaeggi, K.A. (1994) Preclinical Pharmacology of CGP 42’446, a New, Potent, Heterocyclic Bisphosphonate Compound. Journal of Bone and Mineral Research, 9, 745-751.
http://dx.doi.org/10.1002/jbmr.5650090521
|
[12]
|
Menschutkin, N. (1865) Ueber die Einwirkung des Chloracetyles auf Phosphorige Saure. Justus Liebigs Annalen der Chemie, 133, 317-320. http://dx.doi.org/10.1002/jlac.18651330307
|
[13]
|
Fleisch, H., Russell, R.G., Bisaz, S., Casey, P.A. and Muhlbauer, R.C. (1968) The Influence of Pyrophosphate Ana-Logues (Diphosphonates) on the Precipitation and Dissolution of Calcium Phosphate in Vitro and in Vivo. Calcified Tissue Research, 2, 10-10A. http://dx.doi.org/10.1007/BF02065192
|
[14]
|
Ernst, D.S., Brasher, P., Hagen, N., Paterson, A.H., MacDonald, R.N. and Bruera, E. (1997) A Randomized, Controlled Trial of Intravenous Clodronate in Patients with Metastatic Bone Disease and Pain. Journal of Pain and Symptom Management, 13, 319-326. http://dx.doi.org/10.1016/S0885-3924(97)00075-4
|
[15]
|
Rossini, M., Gatti, D., Girardello, S., Braga, V., James, G. and Adami, S. (2000) Effects of Two Intermittent Alendronate Regimens in the Prevention or Treatment of Postmenopausal Osteoporosis. Bone, 27, 119-122.
http://dx.doi.org/10.1016/S8756-3282(00)00291-X
|
[16]
|
Reitsma, P.H., Teitelbaum, S.L., Bijvoet, O.L. and Kahn, A.J. (1982) Differential Action of the Bisphosphonates (3-Amino-1-hydroxypropylidene)-1, 1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-Mediated Bone Resorption in Vitro. Journal of Clinical Investigation, 70, 927-933.
http://dx.doi.org/10.1172/JCI110704
|
[17]
|
Schenk, R., Merz, W.A., Muhlbauer, R., Russell, R.G. and Fleisch, H. (1973) Effect of Ethane-1-hydroxy-1, 1-diphos- phonate (EHDP) and Dichloromethylene Diphosphonate (Cl2MDP) on the Calcification and Resorption of Cartilage and Bone in the Tibial Epiphysis and Metaphysis of Rats. Calcified Tissue Research, 11, 196-214.
http://dx.doi.org/10.1007/BF02547219
|
[18]
|
Miller, S.C. and Jee, W.S. (1979) The Effect of Dichloromethylene Diphosphonate, a Pyrophosphate Analog, on Bone and Bone Cell Structure in the Growing Rat. Anatomical Record, 193, 439-462.
http://dx.doi.org/10.1002/ar.1091930309
|
[19]
|
Ito, M., Amizuka, N., Nakajima, T. and Ozawa, H. (1999) Ultrastructural and Cytochemical Studies on Cell Death of Os-Teoclasts Induced by Bisphosphonate Treatment. Bone, 25, 447-452.
http://dx.doi.org/10.1016/S8756-3282(99)00197-0
|
[20]
|
Coxon, F.P., Helfrich, M.H., Van’t Hof, R., Sebti, S., Ralston, S.H., Hamilton, A. and Rogers, M.J. (2000) Protein Geranylgeranylation Is Required for Osteoclast Formation, Function, and Survival: Inhibition by Bisphosphonates and GGTI-298. Journal of Bone and Mineral Research, 15, 1467-1475. http://dx.doi.org/10.1359/jbmr.2000.15.8.1467
|
[21]
|
Alakangas, A., Selander, K., Mulari, M., Halleen, J., Lehenkari, P., Monkkonen, J., Salo, J. and Vaananen, K. (2002) Alendronate Disturbs Vesicular Trafficking in Osteoclasts. Calcified Tissue International, 70, 40-47.
http://dx.doi.org/10.1007/s002230010047
|
[22]
|
Lehenkari, P.P., Kellinsalmi, M., Napankangas, J.P., Ylitalo, K.V., Monkkonen, J., Rogers, M.J., Azhayey, A., Vaananen, H.K. and Hassinen, I.E. (2002) Further Insight into Mechanism of Action of Clodronate: Inhibition of Mito- Chondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite. Molecular Pharmacology, 61, 1255-1262. http://dx.doi.org/10.1124/mol.61.5.1255
|
[23]
|
Mayahara, M. and Sasaki, T. (2003) Cellular Mechanism of Inhibition of Osteoclastic Resorption of Bone and Calcified Cartilage by Long-Term Pamidronate Administration in Ovariectomized Mature Rats. Anatomical Record Part A, 274, 817-826. http://dx.doi.org/10.1002/ar.a.10092
|
[24]
|
Ralte, S., Khatri, K. and Nagar, M. (2011) Short-Term Effects of Zoledronate on the Histomorphology of Osteoclast in Young Albino Rats. Annals of Anatomy, 193, 509-515. http://dx.doi.org/10.1016/j.aanat.2011.03.009
|
[25]
|
Hughes, D.E., MacDonald, B.R., Russell, R.G. and Gowen, M. (1989) Inhibition of Osteoclast-Like Cell Formation by Bisphosphonates in Long-Term Cultures of Human Bone Marrow. Journal of Clinical Investigation, 83, 1930-1935.
http://dx.doi.org/10.1172/JCI114100
|
[26]
|
Flanagan, A.M. and Chambers, T.J. (1991) Inhibition of Bone Resorption by Bisphosphonates: Interactions between Bisphosphonates, Osteoclasts, and Bone. Calcified Tissue International, 49, 407-415.
http://dx.doi.org/10.1007/BF02555852
|
[27]
|
Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D.D., Golub, E. and Rodan, G.A. (1991) Bisphosphonate Action. Alendronate Localization in Rat Bone and Effects on Osteoclast Ultrastructure. Journal of Clinical Investigation, 88, 2095-2105. http://dx.doi.org/10.1172/JCI115539
|
[28]
|
Vitte, C., Fleisch, H. and Guenther, H.L. (1996) Bisphosphonates Induce Osteoblasts to Secrete an Inhibitor of Osteoclast-Mediated Resorption. Endocrinology, 137, 2324-2333.
|
[29]
|
Murakami, H., Takahashi, N., Sasaki, T., Udagawa, N., Tanaka, S., Nakamura, I., Zhang, D., Barbier, A. and Suda, T. (1995) A Possible Mechanism of the Specific Action of Bisphosphonates on Osteoclasts: Tiludronate Preferentially Affects Polarized Osteoclasts Having Ruffled Borders. Bone, 17, 137-144.
http://dx.doi.org/10.1016/S8756-3282(95)00150-6
|
[30]
|
Hughes, D.E., Wright, K.R., Uy, H.L., Sasaki, A., Yoneda, T., Roodman, G.D., Mundy, G.R. and Boyce, B.F. (1995) Bisphosphonates Promote Apoptosis in Murine Osteoclasts in Vitro and in Vivo. Journal of Bone and Mineral Research, 10, 1478-1487. http://dx.doi.org/10.1002/jbmr.5650101008
|
[31]
|
Derenne, S., Amiot, M., Barille, S., Collette, M., Robillard, N., Berthaud, P., Harousseau, J.L. and Bataille, R. (1999) Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment. Journal of Bone and Mineral Research, 14, 2048-2056. http://dx.doi.org/10.1359/jbmr.1999.14.12.2048
|
[32]
|
Jagdev, S.P., Croucher, P.I. and Shipman, C.M. (2000) Taxol and Zoledronate Induce Apoptosis in Breast Cancer Cells in Vitro: Evidence for Action via Inhibition of Mevalonate Pathway. Bone, 26, S30.
|
[33]
|
Biossier, S., Ferreras, M., Peyruchaud, O., Magnetto, S., Ebetino, F.H., Colombel, M., Delmas, P., Delaissé, J.M. and Clézardin, P. (2000) Biphosphonates Inhibit Breast and Prostrate Carcinoma Cell Invasion, an Early Event in the Formation of Bone Metastases. Cancer Research, 60, 2949-2954.
|